2023-04-19 | NYSEAM:CVM | Press Release | Cel-Sci Corporatio

(2023-04-19 | NYSEAM:CVM) CEL-SCI to Pursue Canada's Conditional Approval Pathway for Multikine in the Treatment of Head & Neck Cancer

Related Keywords

Vienna , Wien , Austria , United States , Baltimore , Maryland , Virginia , Canada , American , Geert Kersten , Health Canada , Exchange Commission , Securities Exchange , Canada Closecurlyquote , Leukocyte Interleukin Injection , Conditions Closecurlydoublequote , Biologics License Application , Leukocyte Interleukin , Orphan Drug , Securities Act , Securities Exchange Act , Cel Sci Corporation , Healthcare 37 , Biotechnology 121 , Usa 8 , Biotechnology 70569 ,